Sfl how to guide final

360 views
294 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
360
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Sfl how to guide final

  1. 1. Prepared March 2011 How-to GuideStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  2. 2. Prepared March 2011 ContentsIntroduction.............................................................................................. 3SFL European Executive Board, Members & Partners.............................. 4Building the Structure................................................................................ 6 Your Local Structure....................................................................... 6 SFL Country Champion................................................................... 6 SFL Steering Committee................................................................. 6 SFL Task Force................................................................................ 7 The SFL National Project Coordinator............................................ 7Situation Analysis and Strategic Planning.................................................. 8 Getting Started................................................................................ 8 Mapping and Analysing Your Situation........................................... 8 Identifying Barriers to the Use of PCI............................................. 9 Defining Objectives and Developing a Strategic Plan..................... 9 Publishing Your Findings.................................................................. 9 Securing Budget.............................................................................. 9 Monitoring Systems and Measuring Success.................................. 10 Securing and Working with Industry Partners.................................. 10Analysis and Planning Case Study.............................................................. 11Template Materials Stent for Life Initiative Action Check List........................................... 13 Stent for Life Initiative Country Situation........................................... 14 Stent for Life Initiative Barriers.......................................................... 15 Stent for Life Initiative Reporting Template........................................ 16For further information contact:Zuzana KaifoszovaSFL Project Manager, EuropeEmail: kaifosz@gmail.comPhone: +420 724 547 303Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  3. 3. Prepared March 2011 IntroductionDear Colleagues,Welcome to the Stent for Life Initiative Toolkit, which I trust you will find useful not only in helping toset up your local Stent for Life Initiative, but also in driving the Initiative forward and achievingpositive change in your country.As you know, the Stent for Life Initiative (SFL) is a unique European platform for interventionalcardiologists, government representatives, industry partners, advocacy groups and patients to worktogether and, by shaping the healthcare systems and medical practices, ensure that the majority ofSTEMI patients will have an equal access to the life saving indication of p-PCI. There are currentlyten countries signed up to SFL: Bulgaria, France, Greece, Serbia, Spain, Turkey (all since 2009),Egypt, Italy, Romania (since 2010) and Portugal (2011).SFL’s overall aim is to improve the delivery and patient access to the life-saving indications of PCI,thereby reducing the mortality and morbidity of patients suffering from acute coronary syndromes.There are two key objectives that will determine our success:1. Define regions and countries with an unmet medical need in the optimal treatment of ACS2. Implement an action programme to increase patient access to p-PCI where indicated: • To increase the use of p-PCI to more than 70% among all STEMI patients • To achieve PCI rates of more than 600 per one million inhabitants per year • To offer 24/7 service for p-PCI procedures at invasive facilities to cover the country STEMI population needAs part of SFL Initiative, your task is to meet these objectives in your country, and this Toolkit willprovide you with guidance to do this. Within these pages you will find advice on all aspects of SFL,including setting up your local SFL structure and Task Force, establishing external partnerships,mapping the local situation, developing a strategic plan and delivering changes in local practice.We urge you to familiarise yourself not only with the current contents, but also any updates we sendas new materials become available.Finally, we would like to thank you for your hard work and commitment to the success of thisimportant initiative. We value your feedback so please do not hesitate to contact us if you have anyquestions or comments on the toolkit.Yours faithfully,Zuzana Kaifoszova Steen D. KristensenStent for Life Initiative Project Manager, Europe Stent for Life Initiative Co-ChairmanStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  4. 4. Prepared March 2011 SFL European Executive Board, Members & PartnersExecutive BoardProf. Steen D. Kristensen, SFL Co-ChairmanDr. Jean Fajadet, SFL Co-Chairman and EAPCI President Elect (2009-2011)Dr. William Wijns, EAPCI past-president (2009-2011)Prof. Carlo di Mario, EAPCI President (2009-2011)Prof. Petr Widimsky, SFL past ChairmanProject ManagementDr. Zuzana Kaifoszova, SFL European Project ManagerMarielle de la Torre, EAPCI Executive OfficerMember CountriesBulgaria, Egypt, France, Greece, Italy, Portugal, Romania, Serbia, Spain and Turkey.Participating Organisations EuroPCR is made up of the winning elements of open-mindedness, innovation and a patient-centred approach, with discussion and debate on the different treatment options in a constructive manner. In line with this, the cardiovascular community identifies the best treatment option for each individual patient. Safe, effective, patient-centred healthcare will help us reduce the burden of cardiovascular disease. Life-saving PCI should be the basis of our daily practice and EuroPCR provides information on the latest techniques, updates and breakthrough science, allowing this information to be turned into actions that will improve the quality of life of the patients. EuroPCR is one of the initiators of SFL, along with the EAPCI. The European Association of Percutaneous Cardiovascular Interventions (EAPCI) is a Registered Branch of the European Society of Cardiology (ESC). It was created in September 2006 as a result of a joint venture between the ESC Working Group on Interventional Cardiology and EuroPCR. EAPCI has over 3100 members and 8 committees. Via its activities, it strives to become “the” exchange forum for all who care about cardiovascular health and wish to contribute to its improvement through the application of percutaneous cardiovascular interventions. The EAPCI is one of the initiators of SFL, along with EuroPCR. The ESC Working Group on Acute Cardiac Care aims to advance the knowledge in major life-threatening fields of cardiology such as acute coronary syndromes, cardiogenic shock, cardiac arrest, cardiac arrhythmias and acute heart failure, by providing training and education to physicians and nurses and by improving the outcome in patients admitted to ICCUs.National Cardiology Societies and/or National Working Groups for Interventional Cardiology(WGIC)Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  5. 5. Prepared March 2011Industry Partners (European Level)Stent for Life Initiative is supported by industry partners, but they have no influence on the scientific content. Abbott Vascular offers a comprehensive device portfolio, including products for carotid and coronary artery, peripheral vascular and structural heart disease, and vessel closure. Biotronik is a leading European company in the field of biomedical technology. It focuses on devices for vascular intervention and electrotherapy of the heart. Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. Cordis Johnson&Johnson is a leading developer and manufacturer of breakthrough stents, catheters and guidewires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology. Eli Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Medtronic is the global leader in medical technology. Medtronic develops and manufactures a wide range of products and therapies providing a continuum of care to diagnose, prevent and monitor chronic conditions. Philips Healthcare is committed to developing tools throughout the complete cycle of care – from disease prevention to screening and diagnosis, to treatment, health management and monitoring – including cardiology, oncology, critical care and women’s health. Terumo Europe manufactures, imports, exports, markets and sells a wide range of products for angiography, cardiology and cardiovascular systems, transfusion, clinical test systems, patient monitoring and diabetes care. The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. Iroko Cardio international Sàrl is a privately held pharmaceutical company located in Geneva, Switzerland and Philadelphia, USA. It manufactures and markets Aggrastat® worldwide (with the exception of the USA) in collaboration with regional distribution partners. Iroko Cardio aims to contribute to the reduction of MACE. Iberhospitex Cordynamics was founded in 1980 by Aniceto López, the current chairman of the group, with the aim of developing innovative, highly performing products. IHT designs, manufactures and markets a wide range of single-use hospital supplies. InspireMD Ltd. is a medical device company focusing on the development and commercialisation of its proprietary stent platform technology – The MGuard net protective stent. MGuard is designed for high risk coronary patients; a market that consists of over two million patients per year worldwide.Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  6. 6. Prepared March 2011Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  7. 7. Prepared March 2011 Building the StructureYour Local StructureGetting the right organisational structure for the Stent for Life Initiative in your country will provideyou with a solid foundation from which to achieve the Initiative’s objectives. It is worth taking the timeto make sure your structure is effective and the best possible people and organisations are involvedand represented.The typical SFL structure looks like this: SFL Country Champion SFL Steering Committee SFL Task Force SFL National Project CoordinatorWe recommend that you mirror this structure unless there are compelling reasons to adopt adifferent one in your country.SFL Country ChampionThe SFL Country Champion is likely to be a well-known and respected cardiologist, and acts as thefigure-head and ambassador for the SFL Initiative. The Country Champion’s roles andresponsibilities include: • Securing support and partnership from the local National Cardiac Society • Leading the SFL Task Force and the development and execution of the Country Implementation Plan • Serving as primary contact for the SFL European Executive Board and SFL Project Manager, Europe • Collecting any available data on AMI treatment in the local country and monitoring how the situation is changing • Leading national level discussions with third parties, including government authorities, healthcare payers, hospitals, etc to facilitate the logistics for improved access to p-PCISFL чемпионом страны, вероятно, будет хорошо известный и уважаемый кардиолог, ион должен выступать в качестве главной фигуры и полпреда SFL инициативы встране. Роль чемпиона страны и обязанности включают в себя:• Обеспечение поддержки и партнерства с Национальным обществом кардиологов;• Руководство SFL Рабочей группой, разработка и реализация Государственного(Регионального) Плана Внедрения SFL инициативы;• Работа в качестве основного контактного лица для SFL ЕвропейскогоИсполнительного Комитета и SFL Европейского проект-менеджера;• сбор любых данных о лечении ОИМ в стране и мониторингапроисходящихизменений;• Проведение дискуссий национального уровня с третьими лицами, в том числеStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  8. 8. Prepared March 2011государственных органов, сферы здравоохранения, больниц и т.д. для облегчениялогистики для улучшения доступа к р-PCISFL Steering CommitteeThe SFL Steering Committee is the scientific body that oversees the gathering of scientific evidencein the country and provides broad strategic oversight for the SFL Initiative. It assists the CountryChampion in leading the SFL Task Force and developing the Country Implementation Plan. TheSteering Committee must be entirely made up of respected cardiologists, patient/advocacy grouprepresentatives or other relevant experts, and should not contain any representatives of industrypartners. The SFL Steering Committee is also responsible for reporting on progress to the SFLEuropean Executive Board.SFL Управляющий Комитет является научным органом, который осуществляет надзорза сбором научных данных в стране и обеспечивает широкий стратегический надзорза проведением SFL инициативы. Она помогает SFL чемпионам страны в руководствеSFL Рабочей группой и в реализации Государственного (Регионального) ПланаВнедрения SFL инициативы. SFL Управляющий Комитет должен состоять изуважаемых кардиологов, представителей групп (обществ) защищающих интересыбольных или других соответствующих специалистов, и не должны содержатьпредставителей партнеров от индустрии. SFL Управляющий Комитет несетответственность за прогресс инициативы и отчетность перед SFL ЕвропейскимИсполнительным Комитетом.SFL Task ForceThe SFL Task Force is responsible for carrying out the Country Implementation Plan, and should bedrawn from representatives of all the key SFL stakeholders who are able to dedicate resources andexpertise. Under the leadership of the SFL Country Champion and Steering Committee, andcoordinated by the National Project Coordinator, the Task Force’s responsibilities include: • Mapping and analysing the local situation • Identifying barriers to effective use of PCI • Securing additional local industry and patient group partners as necessary • Approaching and working with local government as necessary • Developing tactical detail of Country Implementation Plan • Securing and developing budgetsSFL Рабочая группа отвечает за выполнение Государственного (Регионального)Плана Внедрения SFL инициативы, и должны быть представлена членами всехосновных заинтересованных сторон SFL, которые способны отдавать ресурсы и опыт.Под руководством SFL чемпиона страны и Управляющего комитета, и при помощикоординирующих действий National Project Coordinator/Manager, обязанности SFLРабочей группы включают в себя:• Отображение и анализ местной ситуации• выявление препятствий на пути эффективного использования PCI• Обеспечение дополнительной группы партнеров со стороны индустрии ипредставителей групп (обществ) защищающих интересы больных по меренеобходимости• Работа с местными органами власти по мере необходимости• Разработка тактических деталей Государственного (Регионального) ПланаВнедрения SFL• Разработку бюджетовStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  9. 9. Prepared March 2011The SFL National Project Coordinator/ManagerRecruiting the right Project Coordinator is obviously very important to the success of the SFL in yourcountry. Although the Project Coordinator will not set your objectives or determine the strategy, he orshe will be responsible for ensuring that the strategy is carried out and the objectives are met. TheProject Coordinator role will include some or all of the following elements: • Liaison with and reporting to the SFL Steering Committee • Coordination of SFL partners, including the SFL Task Force and the resources at their disposal • Providing administrative support to the SFL Country Champion • Recruitment of additional partners, and securing additional funding if required • Liaison with third parties, including government and patient groups • Liaison with the SFL Project Manager, Europe, and with other SFL National Project Coordinators/Managers • Supporting research projects • Producing written materials, often (but not always) by adapting European templates • Delivering presentations • Understanding of, and liaison with, key media contacts • Understanding of and experience in the field of cardiologyВыбор достойного The SFL National Project Coordinator/Manager, очевидно, оченьважно для успеха SFL в вашей стране. Несмотря на то, The SFL National ProjectCoordinator/Manager не будет устанавливать свои цели и определять стратегию, онили она будет нести ответственность за обеспечение того, чтобы стратегияосуществлялась и задачи выполнялись. Роль координатора проекта будет включать всебя некоторые или все из следующих элементов:• Связь с и отчетности перед SFL Управляющим Комитетом• Координация SFL партнерами, в том числе с SFL Рабочей Группой и ресурсаминаходящимися в их распоряжении• Предоставление административной поддержки SFL Чемпиону страны• Набор дополнительных партнеров, а также обеспечение дополнительногофинансирования в случае необходимости• Взаимодействие с третьими сторонами, включая правительство и группы пациентов• Взаимодействие с SFL Европейским проект-менеджером, так и с другими The SFLNational Project Coordinator/Manager• Поддержка научно-исследовательских проектов• подготовка письменных материалов, часто (но не всегда), адаптируя европейскиешаблоны• Предоставление презентаций• Взаимодействие со СМИ• Понимание и опыт в области кардиологииThe official language of the SFL, at least between countries and at the level of the EuropeanExecutive Board, is English. Therefore, good spoken and written English are essential to the role. Itis also essential that you select a person with a proactive, ‘can-do’ attitude, as the SFL NationalProject Coordinator/Manager will be responsible for driving your projects on a day-to-day basis andensuring successful delivery.Finding a person who can fulfil all of these requirements can be difficult. Good places to startinclude: • The SFL Task Force and local board members – have they worked with a project manager or coordinator in the past who might be suitable?Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  10. 10. Prepared March 2011 • SFL Industry and Advocacy partners – have they worked with anyone suitable? Do they have someone suitable who can be seconded? Can their HR departments help? Can they include a description of the job on the ‘vacancies’ page of their websites? • Recruitment agencies that specialise in the healthcare sectorThe SFL National Project Coordinator/Manager is not hired or contracted by the European Society ofCardiology (ESC), but instead by the national SFL organisation.Официальный язык SFL, по крайней мере, между странами, так и на уровнеЕвропейского Исполнительного Комитета является английский. Таким образом,хороший разговорный и письменный английский язык необходимы для этой роли. Этотакже важно, чтобы выбрать человека с активной позиции ", может, сделать, как TheSFL National Project Coordinator/Manager будет отвечать за ведение Государственного(Регионального) Плана Внедрения SFL инициативы день за днем.Найти человека, который может выполнить все эти требования может быть трудным.Где искать:• Рабочая группа SFL и рекомендуемые ей люди• Среди партнеров SFL по индустрии и пропаганде, рекомендуемые ими люди• Кадровые агентства, которые специализируются в сфере здравоохраненияThe SFL National Project Coordinator/Manager не может быть нанят на работуЕвропейским обществом кардиологов (ESC), но вместо этого может быть принят наработу в национальные SFL организации.Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  11. 11. Prepared March 2011 Situation Analysis and Strategic PlanningGetting StartedWith your structure firmly in place and the right people on board, it is time to move your local SFLinitiative into the analysis and planning phase. Typically, this would involve the following steps: • Mapping and analysing the local situation • Identifying barriers to the use of p-PCI • Developing a strategic plan to overcome those challenges • Implementing that planThis section will provide guidance and suggestions on how to proceed with each of these steps.Начинается работа в рамках SFL инициативы с анализа ситуации и планированиядействий. Как правило, это будет включать в себя следующие этапы:• Отображение и анализ локальной ситуации• выявление препятствий к использованию р-PCI• Разработка стратегического плана для преодоления этих проблем• Осуществление этого планаЭтот раздел содержит рекомендации и предложения о том, как действовать с каждымиз этих шагов.Mapping and Analysing Your Local SituationA good understanding of the local p-PCI situation is obviously essential in order to devise strategiesto change and improve that situation. As a first step, the SFL Task Force should establish thefollowing pieces of information as accurately as possible: • National and regional reperfusion rates • National and regional mortality rates for AMI and ACS • The number and location of p-PCI centres • The number and location of 24/7 p-PCI centres • The ratio of p-PCI centres to overall population • Average time it takes for a patient to arrive at a p-PCI centre, and what kind of transportation (e.g. ambulance, helicopter) is available • What kind of equipment is available within ambulances (e.g. ECG equipment), and the level of training of Emergency Services personnel • The staff allocation for each centre, and what kind of training support staff (including nurses) routinely receive • The proportion of the population that is served by a p-PCI centre within a 90 minute travel window • The differences in service between different cities and different regions – where is the service exemplary; where does it need improvement • The number of interventional cardiologists per capita • Additional details of relevanceNot all this information will be readily available, but it is likely the Task Force will be able to draw onthe resources of the SFL Steering Committee, Industry Partners and affiliated third party groups(including the National Cardiology Society) to find much of the above. These data can be used tobuild an accurate picture of what the p-PCI situation is in your country. We have created a templatetable for you to complete with your relevant country details (see page 14).Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  12. 12. Prepared March 2011It is advised that you also use this data to produce an actual map of the p-PCI situation in yourcountry (network and coverage), as this will help all your stakeholders to better visualise thechallenges you face (see case study example, page 11).We also recommend that you use the mapping exercise to identify p-PCI centres that you canpotentially partner with, either as examples of best practice that you can use for peer-to-peerlearning sessions with other centres, or to help them improve and upgrade the service they offer.You may also want to highlight on your map which centres you are partnering with and the regionswhere most support will be needed.Identifying Barriers to the Use of PCIEach country, once it has finished mapping out its p-PCI situation, must then identify the specificbarriers to effective reperfusion that exist in their country. These may include the following: • Insufficient number or geographical spread of 24/7 cath labs, or sub-optimal staffing (possibly due to insufficient funding or training) • Delayed emergency service response, or inappropriate response, for example taking STEMI patients to the nearest Emergency Room even though it doesn’t have a cath lab • Emergency services are inadequately equipped, for example the ambulance does not have ECG equipment as standard, or personnel are inadequately trained • Low awareness of STEMI symptoms by patients and/or family, leading to delayed contact with emergency servicesWe have developed a table for you to use to help map out your local country barriers (based onpatients, EMS, hospital and organisational) and the target end goals (see page 15).Defining Objectives and Developing a Strategic PlanOnce the local p-PCI situation is mapped out and the barriers identified, you will be well-placed to setyour SFL objectives – referring to the overall SFL three-year objectives outlined in the introductoryletter at the beginning of this toolkit – and determine a strategy to achieve these, including a budget.You may decide your priority is to develop a 24/7 p-PCI network to cover your entire country or tofocus initially on target regions/cities. It may be that the network is already in place, but that anEmergency Services transportation protocol is required, so that ambulance drivers know to by-passthe nearest Emergency Room in favour of the nearest 24/7 cath lab. You may also need toimplement data collection systems so that your progress can be monitored.Once your strategic plan is complete, you will need to present it to the SFL Executive Board forfeedback and approval.Publishing Your FindingsThe objectives and strategy that you set will of course be determined by the unique circumstances inyour country, revealed by the mapping and analysis exercise. It is important that SFL is completelyopen and transparent about its activities and objectives, and that all partners and stakeholders haveaccess to our research results and future plans. We therefore recommend that you write, present (atyour national cardiology congress) and publish (in your national cardiology journal) the results ofyour country mapping exercise, the barriers identified and your proposed solution.When publishing your findings, it is advised that this is always supported by the following mention:‘The Stent for Life Initiative is a joint initiative between the European Association of PercutaneousCardiovascular Interventions (EAPCI), a registered branch of the European Society of Cardiology(ESC), and EuroPCR.’Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  13. 13. Prepared March 2011Securing BudgetImplementing your strategic plan will obviously require funding. It is therefore necessary to securesufficient budget to carry out those plans. The most reliable sources of funding may include: • SFL Industry Partners • Your National Cardiac Society • The larger, more influential patient groups • Government – in particular the health departmentReaching out to all these groups, and any other that are relevant in your country, to secure funds isobviously one of the key factors affecting success, and we encourage you to commit time, resourcesand influential personnel to achieving this goal.Monitoring Systems and Measuring SuccessIt will be important to be able to demonstrate success to your partners, funders and otherstakeholders, most importantly patients at risk of STEMI. It is recommended that you determine whatyour local success will look like, and ways to measure this success, in this initial planning phase.For example, if you decide to implement a consumer awareness campaign, you could considerconducting market research before the launch of the campaign and then after a key milestone inyour campaign to determine if the campaign has had an impact on consumer understanding of thesymptoms of heart attack and the need to call an ambulance quickly.Part of measuring success will also involve monitoring the progress of your local initiatives. Theexact nature of the monitoring system you adopt will depend on the unique circumstances withinyour country. In some cases, you may already have a National p-PCI/STEMI Registry in place. Ifnot, you may want to consider adopting one, so that all cases of p-PCI/STEMI are logged on acentral database, including details such as the time from emergency call to catheterisation and anytime delay during the implementation of p-PCI.Securing and Working with Industry PartnersNumerous Industry partners are already signed up to SFL on a central European level, and theirlocal affiliate companies are obviously natural partners in your country. Additionally, there may beother potential partners in your country. When assessing a potential partner, it is important that theyare aligned with SFL’s goals, and also that they are willing to actively support those goals. Thissupport may include participating in defining strategy, as well as providing expertise such as projectmanagement, local analysis, patient awareness, promotion, funding and investment planning. Theyshould not however, under any circumstances, influence the scientific content of the Initiative.AdministrationReporting ResultsIt is important that the European SFL Steering Committee is kept up to date on the activities andprogress taking place in each of the SFL countries. To help facilitate this, we have developed areporting template (see page 16) which should be completed and emailed to Zuzana Kaifoszova(kaifosz@gmail.com) a month in advance of the two main milestones – EuroPCR in May and ESC inAugust – and at the end of the year (December).Stent for Life Email AddressWe recommend each country to set up a SFL group email address, which includes key countrycontacts, to make it as simple as possible to contact a SFL country. The format that should be usedis as follows: stentforlife_countryname@...Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  14. 14. Prepared March 2011 Analysis and Planning Case Study This account of setting up an SFL initiative in the fictional state of Belovia provides an example of the steps that should be taken when first setting up your local SFL initiative. Belovia is a small land-locked country with a population of 6.5 million. More than half the population live in the capital city, Reperfusia, but the mountainous regions in the North are sparsely populated. Belovia joined SFL in 2009, and quickly appointed its SFL Country Champion, Steering Committee, Task Force and National Project Coordinator. Under the guidance of the Country Champion and the Steering Committee, the Task Force began the mapping process to analyse the p-PCI situation in their country. Key results included the following: • There are 6 national p-PCI centres that operate 24/7, that are potentially within 90 minutes of 85% of the population. However, p-PCI rates are less than 150/mil/year • The average EMS arrival time is over 40 mins after a call is made and most ambulances are not equipped with ECG, meaning that the majority of patients are transferred to the nearest non-PCI hospital • Ambulances responding to emergency calls from the mountainous north can take three to four hours to arrive at a hospital, following which a transfer to a cath lab is often required • The older generations, who lived through the Belovia civil war, are very reluctant to complain about their health, and many do not know the symptoms of STEMI The Belovia SFL Initiative examined these and other data, and determined that their priority objectives would be to: • Greatly reduce the time taken for STEMI patients to present at a cath lab • Educate consumers of all ages on the symptoms and consequences of STEMI The local SFL team then decided upon the following strategies to achieve these objectives: • Provide in-ambulance ECG and training for paramedics to ensure STEMI patients are taken straight to the cath lab with as little delay as possible • Raise funding and political will to provide a helicopter ambulance for the mountainous region in the North • Conduct a consumer awareness campaign to educate older people on the symptoms of STEMI, and also to encourage their children and grandchildren to look after the hearts of their loved onesStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  15. 15. Prepared March 2011Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  16. 16. Prepared March 2011 Stent for Life Initiative Action Checklist Status Action Delivery Date (completed/ongoing/ not-started)Phase 1: Programme Launch SFL Country Champion Appointment Letter of support from National Society SFL Steering Committee Appointed SFL Task Force Appointed SFL National Project Coordinator AppointedPhase 2: Situation Analysis Mapping the local situation Draw map of local situation Defining BarriersPhase 3: Planning and Budget Set three-year measurable objectives Define strategic approach Develop tactical plan and budget Present plan to SFL Executive Board Publish plan and/or present it at cardiology congress Secure budgetStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  17. 17. Prepared March 2011 Stent for Life Initiative Country Situation Country Detail Situation Population Country surface area GDP per capita No. of interventional cardiologists Rate of AMI Rate of AMI mortality Usage rate of PCI Usage rate of thrombolysis Rate of no reperfusion therapy PCI per million p-PCI per million % of p-PCI in STEMI patients No. of cath labs No. of 24/7 cath labs Average distance to cath lab No. of ambulances Average no. of ambulances with ECG Availability of helicopters Yes / No No. of patients that call EMSStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  18. 18. Prepared March 2011 Stent for Life Initiative Barriers Barrier Goal Current SituationPatient Related BarriersEMS Related BarriersHospital Related BarriersOrganisational Related BarriersStent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  19. 19. Prepared March 2011 Stent for Life Initiative Reporting Template Background Information Country [Insert country] Country Champion/ [Insert name] Project Manager [Insert list e.g. governmental figures, patient groups, industry Key Partner Organisations partners, etc] Country Objectives • Key Project Updates Summarise any key updates [e.g. overall progress in achieving objectives, any meetings, and/or progress you have made media campaigns, new partners, etc] in the last 3-6 months, including your key successes Summarise any issues you have [e.g. lack of funding, resistance from policy makers, etc] faced in the last 3-6 months Next Steps Summarise your key activities for [e.g. critical steps and progress in achieving objectives, etc] the next 3-6 months Key milestones and meetings [List any upcoming meetings and/or key milestones and their timing]Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  20. 20. Prepared March 2011 Stent for Life Initiative Reporting Template Background Information Country [Insert country] Country Champion/ [Insert name] Project Manager [Insert list e.g. governmental figures, patient groups, industry Key Partner Organisations partners, etc] Country Objectives • Key Project Updates Summarise any key updates [e.g. overall progress in achieving objectives, any meetings, and/or progress you have made media campaigns, new partners, etc] in the last 3-6 months, including your key successes Summarise any issues you have [e.g. lack of funding, resistance from policy makers, etc] faced in the last 3-6 months Next Steps Summarise your key activities for [e.g. critical steps and progress in achieving objectives, etc] the next 3-6 months Key milestones and meetings [List any upcoming meetings and/or key milestones and their timing]Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR
  21. 21. Prepared March 2011 Stent for Life Initiative Reporting Template Background Information Country [Insert country] Country Champion/ [Insert name] Project Manager [Insert list e.g. governmental figures, patient groups, industry Key Partner Organisations partners, etc] Country Objectives • Key Project Updates Summarise any key updates [e.g. overall progress in achieving objectives, any meetings, and/or progress you have made media campaigns, new partners, etc] in the last 3-6 months, including your key successes Summarise any issues you have [e.g. lack of funding, resistance from policy makers, etc] faced in the last 3-6 months Next Steps Summarise your key activities for [e.g. critical steps and progress in achieving objectives, etc] the next 3-6 months Key milestones and meetings [List any upcoming meetings and/or key milestones and their timing]Stent for Life is a joint initiative between the European Association of Percutaneous CardiovascularInterventions (EAPCI), a registered branch of the European Society of Cardiology (ESC), and EuroPCR

×